Related references
Note: Only part of the references are listed.Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Site-specific glycan analysis of the SARS-CoV-2 spike
Yasunori Watanabe et al.
SCIENCE (2020)
COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
Margaret F. Bassendine et al.
JOURNAL OF DIABETES (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients
Hengzhi Du et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Robert Verity et al.
LANCET INFECTIOUS DISEASES (2020)
Human proline specific peptidases: A comprehensive analysis
Yakov E. Dunaevsky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2020)
Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells
Laura R. Moffitt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
Naveen Vankadari et al.
EMERGING MICROBES & INFECTIONS (2020)
CD26/DPP4-a potential biomarker and target for cancer therapy
Njanja Enz et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
Carolyn F. Deacon
FRONTIERS IN ENDOCRINOLOGY (2019)
Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study
Rohit Bishnoi et al.
CANCER MEDICINE (2019)
Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition
Elodie M. Varin et al.
CELL METABOLISM (2019)
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial
Julio Rosenstock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Circulating fibroblast activation protein and dipeptidyl peptidase 4 in rheumatoid arthritis and systemic sclerosis
Premarani Sinnathurai et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
Devram S. Ghorpade et al.
NATURE (2018)
The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury
Xin M. Wang et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
K. Grehan et al.
METHODSX (2015)
A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation
Brenna Osborne et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)
Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
Tianlei Ying et al.
JOURNAL OF VIROLOGY (2014)
Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry
Wenfei Song et al.
VIROLOGY (2014)
Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs
Fiona M. Keane et al.
FEBS OPEN BIO (2014)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Soluble CD26/Dipeptidyl Peptidase IV Enhances Human Lymphocyte Proliferation In Vitro Independent of Dipeptidyl Peptidase Enzyme Activity and Adenosine Deaminase Binding
D. M. T. Yu et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
Mark Kirby et al.
CLINICAL SCIENCE (2010)
Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies
Gary Frey et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8
Katerina Ajami et al.
FEBS LETTERS (2008)
Expression of the Blomia tropicalis paramyosin Blo t II and its immunodominant peptide in insect cells
Audrey S. M. Teo et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2006)
Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26)
WA Weihofen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
MD Gorrell
CLINICAL SCIENCE (2005)
Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation
K Aertgeerts et al.
PROTEIN SCIENCE (2004)
The purification and characterisation of novel dipeptidyl peptidase IV-like activity from bovine serum
SJ Buckley et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
N-linked glycosylation of dipeptidyl peptidase IV (CD26): Effects on enzyme activity, homodimer formation, and adenosine deaminase binding
K Aertgeerts et al.
PROTEIN SCIENCE (2004)
Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface
WA Weihofen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV
R Thoma et al.
STRUCTURE (2003)
Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family
K Ajami et al.
BIOCHEMISTRY (2003)
Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog
HB Rasmussen et al.
NATURE STRUCTURAL BIOLOGY (2003)
Expression, purification, and characterization of human dipeptidyl peptidase IV/CD26 in Sf9 insect cells
J Dobers et al.
PROTEIN EXPRESSION AND PURIFICATION (2002)
Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8
CA Abbott et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
